Adherium secures US$1.65m shareholder loan
Adherium (ASX:ADR), a digital respiratory management company and developer of the US FDA‑cleared Hailie Smartinhaler, has secured US$1.65 million in short‑term funding via an unsecured loan facility from its major shareholder Trudell Medical to support working capital requirements.










